Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: A retrospective population-based study

The Lancet Oncology

Volumn 17, Issue 1, 2016, Pages 109-114

  Duffy, Stephen W ^a   Dibden, Amanda ^a   Michalopoulos, Dimitrios ^a   Offman, Judith ^a   Parmar, Dharmishta ^a   Jenkins, Jacquie ^b   Collins, Beverley ^c   Robson, Tony ^d   Scorfield, Suzanne ^e   Green, Kathryn ^f   Hall, Clare ^g   Liao, Xiao Hui ^h   Ryan, Michael ^f   Johnson, Fiona ^f   Stevens, Guy ⁱ   Kearins, Olive ^j   Sellars, Sarah ^k   Patnick, Julietta ^k  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c East of England QARC   (United Kingdom)

^d London QARC   (United Kingdom)

^e Yorkshire and Humber QARC   (United Kingdom)

^f North West QARC ^*  (United Kingdom)

^g Northern Ireland QARC   (United Kingdom)

^h South Central QARC   (United Kingdom)

ⁱ PUBLIC HEALTH WALES   (United Kingdom)

^j UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^k Cancer Screening Programme   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INCIDENCE; CANCER PREVENTION; CANCER SCREENING; DISEASE ASSOCIATION; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; INVASIVE INTERVAL BREAST CANCER; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED KINGDOM; WOMEN'S HEALTH; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; INCIDENCE; MIDDLE AGED; PATHOLOGY; TIME FACTOR;

AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; UNITED KINGDOM;

EID: 84955404219     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(15)00446-5     Document Type: Article

References (19)

1. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996, 275:913-918.
2. Paci E, Warwick J, Falini P, Duffy SW Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern?. J Med Screen 2004, 11:23-27.
3. Yen MF, Tabar L, Vitak B, Smith RA, Chen HH, Duffy SW Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening. Eur J Cancer 2003, 39:1746-1754.
4. Allegra CJ, Aberle DR, Ganschow P, et al. National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009. J Natl Cancer Inst 2010, 102:161-169.
5. Duffy SW, Agbaje O, Tabar L, et al. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Res 2005, 7:258-265.
6. Cuzick J, Sestak I, Pinder SE, et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. Lancet Oncol 2011, 12:21-29.
7. Annual Review 2009 2009, NHS Breast Screening Programme, NHS Screening Programmes, Sheffield.
8. Bennett RL, Sellars SJ, Moss SM Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland. Br J Cancer 2011, 104:571-577.
9. Breslow NE, Day NE Statistical Methods in Cancer Research. Vol II. The deisgn and analysis of cohort studies 1987, International Agency for Cancer Research, Lyon.
10. Fracheboud J, de Koning HJ, Beemsterboer PM, et al. Interval cancers in the Dutch breast cancer screening programme. Br J Cancer 1999, 81:912-917.
11. Evans AJ, Pinder SE, Snead DR, Wilson AR, Ellis IO, Elston CW The detection of ductal carcinoma in situ at mammographic screening enables the diagnosis of small, grade 3 invasive tumours. Br J Cancer 1997, 75:542-544.
12. Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 1999, 86:429-438.
13. McCann J, Treasure P, Duffy S Modelling the impact of detecting and treating ductal carcinoma in situ in a breast screening programme. J Med Screen 2004, 11:117-125.
14. Duffy SW, Tabar L, Vitak B, et al. The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease. Eur J Cancer 2003, 39:1755-1760.
15. Tornberg S, Codd M, Rodrigues V, Segnan N, Ponti A Ascertainment and evaluation of interval cancers in population-based mammography screening programmes: a collaborative study in four European centres. J Med Screen 2005, 12:43-49.
16. Bleyer A, Welch HG Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012, 367:1998-2005.
17. Barratt A Overdiagnosis in mammography screening: a 45 year journey from shadowy idea to acknowledged reality. BMJ 2015, 350:h867.
18. Duffy SW, Parmar D Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time. Breast Cancer Res 2013, 15:R41.
19. Anderson TJ, Davis C, Alexander FE, Dobson HM Measures of benefit for breast screening from the pathology database for Scotland, 1991-2001. J Clin Pathol 2003, 56:654-659.